Autologous Stem Cell Transplantation for POEMS Syndrome Chiaki Nakaseko Clinical Lymphoma, Myeloma and Leukemia Volume 14, Issue 1, Pages 21-23 (February 2014) DOI: 10.1016/j.clml.2013.12.009 Copyright © 2014 Elsevier Inc. Terms and Conditions
Figure 1 Efficiency of Stem Cell Mobilization in Patients With POEMS Syndrome. (A) Cyclophosphamide (CY) Plus Granulocyte Colony-Stimulating Factor (G-CSF). (B) G-CSF Alone Clinical Lymphoma, Myeloma and Leukemia 2014 14, 21-23DOI: (10.1016/j.clml.2013.12.009) Copyright © 2014 Elsevier Inc. Terms and Conditions
Figure 2 Overall Survival (OS) and Progression-Free Survival (PFS) After Autologous Stem Cell Transplantation. (A) OS. (B) PFS. Progression was Defined as Elevated Vascular Endothelial Growth Factor Level (≥ 1000 pg/mL) and/or Clinical Relapse Clinical Lymphoma, Myeloma and Leukemia 2014 14, 21-23DOI: (10.1016/j.clml.2013.12.009) Copyright © 2014 Elsevier Inc. Terms and Conditions